 Inflammatory bowel disease combined bacterial immunization oral carrageenan guinea pigs Model development histopathology effects sulfasalazine model induced inflammatory bowel disease IBD colitis Onderdonk co-workers guinea pigs optimal conditions ulcer development time subcutaneous immunization Bacteroides vulgatus concomitant oral administration acid-degraded iota-carrageenan viable vulgatus optimal times agents weeks days Light microscopy colon cecum guinea pigs optimized treatment ulcer induction pronounced edema inflammation lesions mucosa Transmission microscopy mucosa animals presence large numbers leukocytes subepithelial region majority polymorphonuclear neutrophils large electron-dense granules rods Oral administration mg/kg/day sulfasalazine salicylazosulfapyridine days pigs optimized treatment ulcer induction numbers ulcers histopathology gradings fine structural changes mucosal inflammatory changes symptoms diarrhea